Mika Leinonen

6.0k total citations
43 papers, 2.2k citations indexed

About

Mika Leinonen is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mika Leinonen has authored 43 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 15 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mika Leinonen's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (14 papers) and Muscle Physiology and Disorders (8 papers). Mika Leinonen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (14 papers) and Muscle Physiology and Disorders (8 papers). Mika Leinonen collaborates with scholars based in United States, Sweden and Finland. Mika Leinonen's co-authors include Thomas Meier, Karl Kieburtz, C. Warren Olanow, Fabrizio Stocchi, Helena Nissinen, Werner Poewe, Murat Emre, Anthony H.V. Schapira, Olivier Rascol and Christian Rummey and has published in prestigious journals such as Journal of Clinical Oncology, Brain and Neurology.

In The Last Decade

Mika Leinonen

43 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mika Leinonen United States 24 815 716 410 277 248 43 2.2k
M. Chatel France 19 404 0.5× 434 0.6× 113 0.3× 197 0.7× 206 0.8× 78 1.7k
Sébastien Perreault Canada 20 388 0.5× 509 0.7× 156 0.4× 143 0.5× 174 0.7× 70 1.5k
MingMing Ning United States 31 1.0k 1.3× 790 1.1× 94 0.2× 237 0.9× 529 2.1× 86 3.0k
Avelina Tortosa Spain 27 235 0.3× 1.3k 1.8× 475 1.2× 349 1.3× 263 1.1× 50 2.4k
Jennifer M. Johnson United States 25 267 0.3× 612 0.9× 847 2.1× 306 1.1× 364 1.5× 104 2.3k
Yohei Mineharu Japan 29 906 1.1× 507 0.7× 281 0.7× 82 0.3× 405 1.6× 128 2.4k
Ewa Matyja Poland 24 414 0.5× 614 0.9× 135 0.3× 285 1.0× 184 0.7× 127 1.9k
Bernard Lemieux Canada 25 672 0.8× 1.0k 1.4× 232 0.6× 550 2.0× 223 0.9× 84 2.2k
Marie‐Bernadette Delisle France 27 447 0.5× 1.0k 1.4× 291 0.7× 165 0.6× 207 0.8× 95 2.4k
Margaret L. Ramnaraine United States 19 138 0.2× 687 1.0× 742 1.8× 269 1.0× 132 0.5× 38 2.0k

Countries citing papers authored by Mika Leinonen

Since Specialization
Citations

This map shows the geographic impact of Mika Leinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Leinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Leinonen more than expected).

Fields of papers citing papers by Mika Leinonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Leinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Leinonen. The network helps show where Mika Leinonen may publish in the future.

Co-authorship network of co-authors of Mika Leinonen

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Leinonen. A scholar is included among the top collaborators of Mika Leinonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Leinonen. Mika Leinonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olanow, C. Warren, Deborah McIntyre, Michele Matarazzo, et al.. (2024). Continuous Levodopa Delivery with an Intraoral Micropump System: An Open‐Label Pharmacokinetics and Clinical Study. Movement Disorders. 39(6). 945–954. 5 indexed citations
2.
Olanow, C. Warren, Alberto J. Espay, Fabrizio Stocchi, et al.. (2020). Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study. Journal of Parkinson s Disease. 11(1). 177–186. 35 indexed citations
3.
Kósa, Péter, Tianxia Wu, Jonathan A. Phillips, et al.. (2020). Idebenone does not inhibit disability progression in primary progressive MS. Multiple Sclerosis and Related Disorders. 45. 102434–102434. 26 indexed citations
4.
Buyse, Gunnar, Christian Rummey, Thomas Meier, et al.. (2018). Home-Based Monitoring of Pulmonary Function in Patients with Duchenne Muscular Dystroph. Journal of Neuromuscular Diseases. 5(4). 419–430. 10 indexed citations
5.
6.
Olanow, C. Warren, Karl Kieburtz, Mika Leinonen, et al.. (2017). A randomized trial of a low‐dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease. Movement Disorders. 32(5). 783–789. 26 indexed citations
7.
Buyse, Gunnar, Thomas Voït, Ulrike Schara, et al.. (2016). Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy. Pediatric Pulmonology. 52(4). 508–515. 33 indexed citations
8.
Hampson, Neil B., Karl Kieburtz, Peter A. LeWitt, Mika Leinonen, & Martin I. Freed. (2016). Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations. International Journal of Neuroscience. 127(3). 276–284. 16 indexed citations
9.
Kullenberg, Torbjörn, et al.. (2016). Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes. Lara D. Veeken. 55(8). 1499–1506. 100 indexed citations
10.
Eriksson, Mikael, Peter Reichardt, Kirsten Sundby Hall, et al.. (2016). Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour – Does it increase the risk for tumour cell seeding and recurrence?. European Journal of Cancer. 59. 128–133. 28 indexed citations
11.
Stiff, Patrick J., et al.. (2015). Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis. Biology of Blood and Marrow Transplantation. 22(1). 164–169. 12 indexed citations
12.
Kuoppamäki, Mikko, Mika Leinonen, & Werner Poewe. (2015). Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off. Journal of Neural Transmission. 122(12). 1709–1714. 19 indexed citations
13.
Leinonen, Mika, B. Hallén, & Hans Olivecrona. (2014). A2: Rapid and Sustained Response in Patients Suffering From Severe Cryopyrin‐Associated Periodic Syndromes Treated With Anakinra (Kineret®). Arthritis & Rheumatology. 66(S3). 2 indexed citations
14.
15.
Joensuu, Heikki, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen, et al.. (2013). Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). Acta Oncologica. 53(2). 186–194. 22 indexed citations
16.
Vardas, Eftyhia, Mika Leinonen, Kim Ellefsen, et al.. (2012). Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects. Vaccine. 30(27). 4046–4054. 32 indexed citations
17.
Rudolph, Guenther, Konstantinos Dimitriadis, Boriana Büchner, et al.. (2012). Effects of Idebenone on Color Vision in Patients With Leber Hereditary Optic Neuropathy. Journal of Neuro-Ophthalmology. 33(1). 30–36. 61 indexed citations
18.
Aalto, Sargo, Noora M. Scheinin, Nina Kemppainen, et al.. (2009). Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data. European Journal of Nuclear Medicine and Molecular Imaging. 36(10). 1651–1660. 24 indexed citations
19.
Brooks, David J., Mika Leinonen, Mikko Kuoppamäki, & Helena Nissinen. (2008). Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson’s disease. Journal of Neural Transmission. 115(6). 843–849. 25 indexed citations
20.
Paija, Outi, Kari Laine, Mika Leinonen, et al.. (2005). Entacapone Increases Levodopa Exposure and Reduces Plasma Levodopa Variability When Used With Sinemet CR. Clinical Neuropharmacology. 28(3). 115–119. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Chatel Breakdown of academic impact, for papers by Sébastien Perreault Breakdown of academic impact, for papers by MingMing Ning Breakdown of academic impact, for papers by Avelina Tortosa Breakdown of academic impact, for papers by Jennifer M. Johnson Breakdown of academic impact, for papers by Yohei Mineharu Breakdown of academic impact, for papers by Ewa Matyja Breakdown of academic impact, for papers by Bernard Lemieux Breakdown of academic impact, for papers by Marie‐Bernadette Delisle Breakdown of academic impact, for papers by Margaret L. Ramnaraine
Rankless by CCL
2026